The optimal blood pressure target for patients with coronary artery disease

Current Cardiology Reports

Volumn 12, Issue 4, 2010, Pages 302-306

  Verdecchia, Paolo ^a   Angeli, Fabio ^a   Cavallini, Claudio ^a   Mazzotta, Giovanni ^a   Garofoli, Marta ^a   Martire, Paola ^a   Reboldi, Gianpaolo ^a  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

Author keywords

Antihypertensive therapy; Blood pressure; Coronary artery disease; Epidemiology; Hypertension; J curve; Myocardial infarction; Stroke

Indexed keywords

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; PATHOPHYSIOLOGY; PATIENT CARE; PRACTICE GUIDELINE; PROGNOSIS; REVIEW; RISK REDUCTION; SYSTOLIC BLOOD PRESSURE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CORONARY ARTERY DISEASE; HUMANS; HYPERTENSION; MYOCARDIAL INFARCTION; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS; STROKE; SYSTOLE;

EID: 77956395264     PISSN: 15233782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11886-010-0112-y     Document Type: Review

References (25)

1. Kotseva K, Wood D, De Backer G, et al.: Cardiovascular prevention guidelines in daily practice: A comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet 2009, 373:929-940. This paper describes the European registry of the state of control of cardiovascular risk factors.
2. Grossman W, Jones D, McLaurin LP: Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 1975, 56:56-64.
3. Klocke FJ: Measurements of coronary flow reserve: Defining pathophysiology versus making decisions about patient care. Circulation 1987, 76:1183-1189.
4. Polese A, De Cesare N, Montorsi P, et al.: Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle. Circulation 1991, 83:845-853.
5. Cruickshank J: The J-curve in hypertension. Curr Cardiol Rep 2003, 5:441-452.
6. Pepi M, Alimento M, Maltagliati A, Guazzi MD: Cardiac hypertrophy in hypertension. Repolarization abnormalities elicited by rapid lowering of pressure. Hypertension 1988, 11:84-91.
7. Rosendorff C, Black HR, Cannon CP, et al.: Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007, 115:2761-2788. This is the Scientific Statement of the American Heart Association on the prevention and management of coronary artery disease in hypertensive patients.
8. Mancia G, Laurent S, Agabiti-Rosei E, et al.: Reappraisal of European guidelines on hypertension management: A European Society of Hypertension Task Force document. J Hypertens 2009, 27:2121-2158. This is the guideline document of the European Society of Hypertension.
9. MacMahon S, Peto R, Cutler J, et al.:. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias. Lancet 1990, 335:765-774.
10. Lewington S, Clarke R, Qizilbash N, et al.: Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
11. Staessen JA, Gasowski J, Wang JG, et al.: Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 2000, 355:865-872.
12. Collins R, MacMahon S: Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease. Br Med Bull 1994, 50:272-298.
13. Staessen JA, Wang JG, Thijs L: Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001, 358:1305-1315.
14. Turnbull F: Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials. Lancet 2003, 362:1527-1535.
15. Anderson TW: Re-examination of some of the Framingham blood-pressure data. Lancet 1978, 2:1139-1141.
16. Stewart IM: Relation of reduction in pressure to first myocardial infarction in patients receiving treatment for severe hypertension. Lancet 1979, 1:861-865.
17. Cruickshank JM, Thorp JM, Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1987, 1:581-584.
18. Farnett L, Mulrow CD, Linn WD, et al.: The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous? JAMA 1991, 265:489-495.
19. Cruickshank JM: Antihypertensive treatment and the J-curve. Cardiovasc Drugs Ther 2000, 14:373-379.
20. Messerli FH, Mancia G, Conti CR, et al.: Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006, 144:884-893.
21. Marschner IC, Simes RJ, Keech A: Biases in the identification of risk factor thresholds and J-curves. Am J Epidemiol 2007, 166:824-831. This is an important methodologic paper clarifying the impact of residual risk factors, as potential confounders, on the J-shaped curve.
22. Vasan RS: Pathogenesis of elevated peripheral pulse pressure: Some reflections and thinking forward. Hypertension 2008, 51:33-36.
23. Sipahi I, Tuzcu EM, Schoenhagen P, et al.: Effects of normal, prehypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006;48:833-838.
24. Verdecchia P, Staessen JA, Angeli F, et al.: Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): An open-label randomised trial. Lancet 2009, 374:525-533. This is a randomized intervention study comparing two different systolic BP targets in hypertensive patients.
25. Sleight P, Redon J, Verdecchia P, et al.: Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 2009, 27:1360-1369.